A combination of metal-catalyzed cross-coupling and metal-templated cycloaddition reactions have been utilized to establish multiporphyrin compounds 5-(5'-[15',15' '-bis(10' ',20' '-di[4-(3-methoxy-3-methylbutoxy)phenyl]porphinato)zinc(II)]ethyne)-6-[(5' "-10' ",20' "-di[4-(3-methoxy-3-methylbutoxy)phenyl]porphinato)zinc(II)]indane (1) and 5,6-bis(5'-15',15' '-bis[(10',20'-di[4-(3-methoxy-3-methylbutoxy)phenyl]porphinato)zinc(II)]ethyne)indane (2). Compounds 1 and 2 feature a covalently bridged cofacial bis(porphinato)metal core; ethyne bridging moieties conjugate directly one and two respective peripheral (porphinato)zinc(II) substituents to the macrocyclic framework of their corresponding face-to-face porphyrin units. Optical spectroscopy and electrochemical studies demonstrate substantive electronic interactions between the porphyrin subunits of these compounds. Notably, structural and (1)H NMR analyses verify that 1 and 2 possess open conformations necessary for binding small molecules within their respective cofacial (porphinato)metal cores.
No takes yet. Share an insight, caveat, or question.
FLETCHER et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: